<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>929</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>10747114</PubmedId>
            <Abstract>A recombinant rabies virus phosphoprotein fusion product (GST-P) was used to generate a series of monoclonal antibodies (MAbs) with anti-P reactivity. Competitive binding assays classified 27 of these MAbs into four groups (I to IV), and 24 of them were deemed to recognize linear epitopes, as judged by their reaction in immunoblots. The linear epitope recognized in each case was mapped by using two series of N- and C-terminally deleted recombinant phosphoproteins. Assessment of the reactivities of representative MAbs to a variety of lyssavirus isolates by an indirect fluorescent antibody test indicated that group I MAbs, which recognized a highly conserved N-terminal epitope, were broadly cross-reactive with all lyssaviruses assayed, while group III MAbs, which reacted with a site overlapping that of group I MAbs, exhibited variable reactivities and group IV MAbs reacted with most isolates of genotypes 1, 6, and 7 only. In contrast, group II MAbs, which recognized an epitope located within a highly divergent central portion of the protein, were exquisitely strain specific. These anti-P MAbs are potentially useful tools for lyssavirus identification and discrimination.</Abstract>
            <ArticleYear>2000</ArticleYear>
            <ArticlePages>1397-403</ArticlePages>
            <ArticleTitle>A panel of monoclonal antibodies targeting the rabies virus phosphoprotein identifies a highly variable epitope of value for sensitive strain discrimination.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Nadin-Davis</LastName>
                    <ForeName>S A</ForeName>
                </Author>
                <Author>
                    <LastName>Sheen</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Abdel-Malik</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Elmgren</LastName>
                    <ForeName>L</ForeName>
                </Author>
                <Author>
                    <LastName>Armstrong</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Wandeler</LastName>
                    <ForeName>A I</ForeName>
                </Author>
            </Authors>
            <Affiliations>Rabies Centre of Expertise, Animal Diseases Research Institute, Canadian Food Inspection Agency, Nepean, Ontario, Canada. nadindaviss@em.agr.ca.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Antibodies, Viral;Molecular Chaperones;P phosphoprotein, Rabies virus;Peptides;Phosphoproteins;Recombinant Fusion Proteins;Viral Structural Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antibodies, Monoclonal(biosynthesis; classification; immunology); Antibodies, Viral(immunology); Binding, Competitive; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Epitope Mapping; Lyssavirus(classification; immunology); Mice; Mice, Inbred BALB C; Molecular Chaperones; Peptides(chemical synthesis; immunology); Phosphoproteins(genetics; immunology; metabolism); Rabies virus(classification; immunology); Recombinant Fusion Proteins(immunology); Sensitivity and Specificity; Viral Structural Proteins(genetics; immunology; metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>38</Volume>
                <Issue>4</Issue>
                <Title>Journal of clinical microbiology</Title>
                <Issn>1098-660X</Issn>
                <MedlineTa>J Clin Microbiol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>PVEP3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KKETTSISSQRDSQSSKA</LinearSequence>
                        <StartingPosition>154</StartingPosition>
                        <EndingPosition>171</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAK54996.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>37132</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 1398</LocationOfData>
                <EpitopeId>31531</EpitopeId>
                <ReferenceStartingPosition>154</ReferenceStartingPosition>
                <ReferenceEndingPosition>171</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>N terminal Cys is not part of the natural epitope sequence. This peptide is shown to reside in antigenic region II of source protein, highly source species specific, with mAbs recognizing this region unable to react with 31 other lyssaviruses assayed.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure  2A</LocationOfData>
                        <BCellId>10634</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAK54996.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>37132</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Phosphoprotein (P protein)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>TiterMax</Adjuvant>
                                <DoseSchedule>2 doses.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>1st immunization with crude extract of E.coli expressing recombinant GST-source protein. Before spleen collection,  a boost with purified GST-source protein fusion was given.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>311</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>This peptide was able to compete binding to source protein of mAbs directed to antigenic site II, previously defined to reside in aa 145-165. This of data suggests that the antigenic region is aa 154-168. This region is highly source species specific, with mAbs recognizing this region unable to react with 31 other lyssaviruses assayed.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>M958, M977, M960</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>PVEP3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KKETTSISSQRDSQSSKA</LinearSequence>
                                        <StartingPosition>154</StartingPosition>
                                        <EndingPosition>171</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAK54996.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>37132</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>I or III</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AHLQGEPIEVDNLPEDMKRLQLDDKKPSGL</LinearSequence>
                        <StartingPosition>37</StartingPosition>
                        <EndingPosition>66</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAK54996.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>37132</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>1795</EpitopeId>
                <ReferenceStartingPosition>37</ReferenceStartingPosition>
                <ReferenceEndingPosition>66</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This region of source protein is shown by competition among different mAbs to contain 2 antigenic regions. mAbs reacting to this region are highly cross-reactive to rabies and rabies related lyssaviruses.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Tables 2 and 3</LocationOfData>
                        <BCellId>10637</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAK54996.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>37132</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Phosphoprotein (P protein)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>TiterMax</Adjuvant>
                                <DoseSchedule>2 doses.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>1st immunization with crude extract of E.coli expressing recombinant GST-source protein. Before spleen collection,  a boost with purified GST-source protein fusion was given.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>A truncated version of the source protein was recognized by mAbs directed to the antigenic sites I and III, previously defined by competition ELISA. These regions are highly cross-reactive, with mAbs recognizing these regions reacting with 30 other lyssaviruses assayed, but not with non-lyssavirus rhabdoviruses.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>I or III</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AHLQGEPIEVDNLPEDMKRLQLDDKKPSGL</LinearSequence>
                                        <StartingPosition>37</StartingPosition>
                                        <EndingPosition>66</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAK54996.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>37132</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>IV</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LMDEGEDPSLLFQSYLDNVGVQIVRQMRSGER</LinearSequence>
                        <StartingPosition>82</StartingPosition>
                        <EndingPosition>113</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAK54996.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>37132</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>38005</EpitopeId>
                <ReferenceStartingPosition>82</ReferenceStartingPosition>
                <ReferenceEndingPosition>113</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This region of source protein is shown by competition among different mAbs to contain 1 antigenic region. MAbs reacting to this region are highly cross-reactive to rabies and rabies related lyssaviruses with genotypes 1, 6 and 7, but not reactivity is seen against LBK, MOKV, DUVV and nonlyssavirus rhabdoviruses.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Tables 2 and 3</LocationOfData>
                        <BCellId>10638</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAK54996.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>37132</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Phosphoprotein (P protein)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC240127</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>562</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>TiterMax</Adjuvant>
                                <DoseSchedule>2 doses.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>1st immunization with crude extract of E.coli expressing recombinant GST-source protein. Before spleen collection,  a boost with purified GST-source protein fusion was given.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>A truncated version of the source protein was recognized by mAbs directed to antigenic site IV, previously defined by competition ELISA. This region is highly cross-reactive, with mAbs recognizing this region reacting with 26 other lyssaviruses assayed, but not with non-lyssavirus rhabdoviruses.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>IV</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LMDEGEDPSLLFQSYLDNVGVQIVRQMRSGER</LinearSequence>
                                        <StartingPosition>82</StartingPosition>
                                        <EndingPosition>113</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAK54996.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>37132</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

